Charles Pauling Semba

Insider Reports History

Location
Minneapolis, MN
Signature
/s/ Scott Kellen, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles Pauling Semba:

Company Role Class Num Shares Value Price $ Report Date Ownership
DiaMedica Therapeutics Inc. Director Common Stock 47,963 $403,848 $8.42 02 Jan 2026 Direct
DiaMedica Therapeutics Inc. Director Stock Option (right to buy) 32,162 01 Jun 2025 Direct

Insider Reports Filed by Charles Pauling Semba

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DMAC DiaMedica Therapeutics Inc. 02 Jan 2026 1 +$28,249 4 Director 06 Jan 2026, 17:22
DMAC DiaMedica Therapeutics Inc. 01 Jun 2025 1 $0 4 Director 03 Jun 2025, 16:18
DMAC DiaMedica Therapeutics Inc. 02 Jan 2025 1 +$28,249 4 Director 03 Jan 2025, 16:15
DMAC DiaMedica Therapeutics Inc. 01 Jun 2024 1 $0 4 Director 03 Jun 2024, 16:35
DMAC DiaMedica Therapeutics Inc. 02 Jan 2024 1 +$26,250 4 Director 02 Jan 2024, 17:05
DMAC DiaMedica Therapeutics Inc. 23 Jun 2023 1 +$49,997 4 Director 26 Jun 2023, 16:26
DMAC DiaMedica Therapeutics Inc. 01 Jun 2023 1 $0 4 Director 02 Jun 2023, 16:33
DMAC DiaMedica Therapeutics Inc. 03 Jan 2023 1 +$26,249 4 Director 03 Jan 2023, 15:25
DMAC DiaMedica Therapeutics Inc. 01 Jun 2022 1 $0 4 Director 02 Jun 2022, 16:34
DMAC DiaMedica Therapeutics Inc. 15 Jul 2021 1 $0 4 Director 16 Jul 2021, 16:21
DMAC DiaMedica Therapeutics Inc. 15 Jul 2021 0 $0 3 Director 16 Jul 2021, 16:16